Nitric oxide is a mediator of methamphetamine (METH)-induced neurotoxicity. In vitro evidence from primary cultures of mesencephalic cells

Annals of the New York Academy of Sciences

Volumn 801, Issue , 1996, Pages 174-186

  Sheng, Peilin ^a   Cerruti, Catherine ^a   Ali, Syed ^b   Cadet, Jean Lud ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; BENZAMIDE; COPPER ZINC SUPEROXIDE DISMUTASE; DOPAMINE; FREE RADICAL; METHAMPHETAMINE; NICOTINAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; FETUS; MESENCEPHALON; MOUSE; NERVE ENDING; NEUROTOXICITY; NONHUMAN; OXIDATION; RAT; TRANSGENE;

ANIMALIA; MUS MUSCULUS;

EID: 0030464114     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb17440.x     Document Type: Conference Paper

References (42)

1. BAKHIT, C., M. E. MORGAN, M. A. PEAT & J. W. GIBB. 1981. Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain. Neuropharmacology 20: 1135-1140.
2. BECKMAN, J. S. 1991. The double-edged role of nitric oxide in brain and superoxide-mediated injury. J. Dev. Physiol. 15: 53-59.
3. BENNETT, B. A., C. E. HYDE, J. R. PECORA & J. E. CLODFELTER. 1993. Differing neurotoxic potencies of methamphetamine, mazindol, and cocaine in mesencephalic cultures. J. Neurochem. 60: 1444-1452.
4. CADET, J. L. 1988. A unifying hypothesis of movement and madness: involvement of free radicals in disorders of the isodendritic core. Med. Hypotheses 27: 87-94.
5. CADET, J. L., P. SHENG, S. ALI, R. ROTHMAN, E. CARLSON & C. J. EPSTEIN. 1994. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62: 380-383.
6. CARSON, D. A., S. SETO, D. B. WASON & C. J. CARRERA. 1986. DNA strand breaks, NAD metabolism and programmed cell death. Exp. Cell Res. 164: 273-281.
7. COHEN, G. & R. E. HEIKKILA. 1974. The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 249: 2447-2452.
8. COMMINS, D. L., G. VOSMER, R. M. VIRUS, W. L. WOOLVERTON, C. R. SCHUSTER & L. S. SEIDEN. 1987. Biochemical and histological evidence that methylendioxymethamphetamine (MDMA) is toxic to neurons in rat brain. J. Pharmacol. Exp. Ther. 241: 338-345.
9. COYLE, J. T. & P. PUTTFARCKEN. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695.
10. CUBELLS, J. F., S. RAYPORT, G. RAJNDRON & D. SULZER. 1994. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14: 2260-2271.
11. DAWSON, V. L., T. M. DAWSON, D. A. BARTLEY, G. R. UHL & S. H. SNYDER. 1993. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13: 2651-2661.
12. DE VITO, M. J. & G. C. WAGNER. 1989. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 28: 1145-1150.
13. EPSTEIN, C. J., K. B. AVRAHAM, M. LOVETT, S. SMITH, O. ELROY-STEIN, G. ROTMAN, C. BRY & Y. GRONER. 1987. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. USA 84: 8044-8048.
14. GIBB, J. W. & F. G. KOGAN. 1979. Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase. Naunyn-Schmeideberg's Arch. Pharmacol. 310: 185-187.
15. JOHNSON, M., D. M. STONE, G. R. HANSON & J. W. GIBB. 1987. Role of the nigrostriatal pathway in methamphetamine-induced depression of neostriatal serotonergic system. Eur. J. Pharmacol. 135: 231-234.
16. KOGAN, F. J., W. K. NICHOLS & J. W. GIBB. 1976. Influence of methamphetamine on nigral and striatal hydroxylase activity and striatal dopamine levels. Eur. J. Pharmacol. 36: 363-371.
17. KONTUR, P. J., P. C. HOFFMAN & A. HELLER. 1987. Neurotoxic effects of methamphetamine assessed in three-dimensional re-aggregate tissue cultures. Dev. Brain Res. 31: 7-14.
18. KONTUR, P. J., L. A. WON, P. C. HOFFMAN & A. HELLER. 1991. Survival of developing dopaminergic neurons in re-aggregate tissue culture following treatment with methamphetamine. Neurosci. Lett. 129: 254-258.
19. 3H]cyanoimipramine autoradiography. Brain Res. 505: 123-129.
20. MANTLE, T. J., K. F. TIPTON & N. J. GARRETT. 1976. Inhibition of monoamine oxidase by amphetamine and related compounds. Biochem. Pharmacol. 25: 2073-2077.
21. MAREK, G. J., G. VOSMER & L. S. SEIDEN. 1990. Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Res. 513: 274-279.
22. MARSHALL, J. F., S. J. O'DELL & F. B. WEIHMULLER. 1993. Dopamine-glutamate interactions in methaphetamine-induced neurotoxicity. J. Neural Transm. 91: 241-254.
23. MONCADA, S., R. M. J. PALMER & E. A. HIGGS. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142.
24. NATHAN, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064.
25. OLANOW, C. W. 1993. A radical hypothesis for neurodegeneration. TINS 16: 439-444.
26. POU, S., W. S. POU, D. S. BREDT, S. H. SNYDER & G. M. ROSEN. 1992. Generation of superoxide by purified brain nitric oxide synthase. J. Biol. Chem. 267: 24173-24176.
27. RADI, R., J. S. BECKMAN, K. M. BUSH & B. A. FREEMAN. 1991. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288: 481-487.
28. RICAURTE, G. A., C. R. SCHUSTER & L. S. SEIDEN. 1980. Long-term effects of repeated methamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 193: 151-163.
29. ROSENBERG, P. A. 1988. Catecholamine toxicity in cerebral cortex in dissociated cell culture. J. Neurosci. 8: 2887-2894.
30. SCHMIDT, C. J., J. K. RITTER, P. K. SONSALLA, G. R. HANSSON & J. W. GIBB. 1985. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233: 539-544.
31. SCHMIDT, C. J., P. K. SONSALLA, G. R. HANSON, M. A. PEAT & J. W. GIBB. 1985. Methamphetamine-induced depression of monoamine synthesis in the rat: development of tolerance. J. Neurochem. 44: 852-855.
32. SCHRAUFSTATTER, I. U., D. B. HINSHAW, P. A. HYSLOP, R. G. SPRAGG & C. G. COCHRANE. 1986a. Oxidant injury of cells: DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J. Clin. Invest. 77: 1312-1320.
33. SCHRAUFSTATTER, I. U., P. A. HYSLOP, D. B. MINSHAW, R. G. SPRAGG, L. A. SKLAR & C. G. COCHRANE. 1986b. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA 83: 4908-4912.
34. SEIDEN, L. S., M. W. FISCHMAN & C. R. SCHUSTER. 1975. Long-term methamphetamine-induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1: 215-219.
35. SHENG, P., C. CERUTTI & J. L. CADET. 1994. Methamphetamine (METH) causes reactive gliosis in vitro: attenuation by the ADP-ribosylation (ADPR) inhibitor, benzamide. Life Sci. 55: 51-54.
36. SONSALLA, P. K., W. J. NICKLAS & R. E. HEIKKILA. 1989. Role for excitatory amino acids in methamphetamine-induced dopaminergic toxicity. Science 243: 398-400.
37. SONSALLA, P. K., D. E. RIORDAN & R. E. HEKKILA. 1991. Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J. Pharmacol. Exp. Ther. 256: 506-512.
38. SULZER, D. & S. RAYPORT. 1990. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5: 797-808.
39. SULZER, D., N. T. MAIDMENT & S. RAYPORT. 1993. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60: 527-535.
40. WAGNER, G. C., G. A. RICAURTE, L. S. SEIDEN, C. R. SCHUSTER, R. J. MILLER & J. WESTLEY. 1980. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181: 151-160.
41. WEIHMULLER, F. B., S. J. O'DELL & J. F. MARSHALL. 1992. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse 11: 155-163.
42. ZHANG, J., V. L. DAWSON, T. M. DAWSON & S. H. SNYDER. 1994. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263: 687-689.